Last updated on February 2018

Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of eldecalcitol monotherapy compared with alfacalcidol monotherapy in patients with glucocorticoid-induced osteoporosis, using a randomized, open-label, parallel-group, comparative design.

Clinical Study Identifier: NCT01974167

Find a site near you

Start Over